Skip to content
10-Q

Quarterly Report

Sarepta Therapeutics, Inc. SRPT

0000950170-25-103971

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 97.71M sh
Shares Diluted Q2 2025 · Jun 30, 2025 106.62M sh
Shares Diluted Q2 2025 · Jun 30, 2025 97.69M sh
Shares Diluted Q2 2025 · Jun 30, 2024 99.14M sh
Shares Diluted Q2 2025 · Jun 30, 2024 99.13M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $25.01M
Stock Repurchased Q2 2025 · Jun 30, 2024 $0
Capex Q2 2025 · Jun 30, 2025 $75.45M
Capex Q2 2025 · Jun 30, 2024 $61.61M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$322.1M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$227.13M
Short Term Investments Q2 2025 · Jun 30, 2025 $289.54M
Short Term Investments Q2 2025 · Dec 31, 2024 $251.78M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $510.6M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $1.1B
Cash And Equivalents Q2 2025 · Jun 30, 2024 $383.62M
Stockholders Equity Q2 2025 · Jun 30, 2025 $1.36B
Stockholders Equity Q2 2025 · Mar 31, 2025 $1.14B
Stockholders Equity Q2 2025 · Dec 31, 2024 $1.53B
Stockholders Equity Q2 2025 · Jun 30, 2024 $1.08B
Stockholders Equity Q2 2025 · Mar 31, 2024 $961.19M
Stockholders Equity Q2 2025 · Dec 31, 2023 $859.34M
Current Liabilities Q2 2025 · Jun 30, 2025 $919.95M
Current Liabilities Q2 2025 · Dec 31, 2024 $731.68M
Total Liabilities Q2 2025 · Jun 30, 2025 $2.32B
Total Liabilities Q2 2025 · Dec 31, 2024 $2.44B
Current Assets Q2 2025 · Jun 30, 2025 $2.66B
Current Assets Q2 2025 · Dec 31, 2024 $3.07B
Total Assets Q2 2025 · Jun 30, 2025 $3.68B
Total Assets Q2 2025 · Dec 31, 2024 $3.96B
Eps Diluted Q2 2025 · Jun 30, 2025 $1.89
Eps Diluted Q2 2025 · Jun 30, 2025 −$2.57
Eps Diluted Q2 2025 · Jun 30, 2024 $0.07
Eps Diluted Q2 2025 · Jun 30, 2024 $0.44
Eps Basic Q2 2025 · Jun 30, 2025 $2.01
Eps Basic Q2 2025 · Jun 30, 2025 −$2.57
Eps Basic Q2 2025 · Jun 30, 2024 $0.07
Eps Basic Q2 2025 · Jun 30, 2024 $0.45
Sga Expense Q2 2025 · Jun 30, 2025 $137.9M
Sga Expense Q2 2025 · Jun 30, 2025 $271.53M
Sga Expense Q2 2025 · Jun 30, 2024 $138.8M
Sga Expense Q2 2025 · Jun 30, 2024 $265.8M
Net Income Q2 2025 · Jun 30, 2025 $196.89M
Net Income Q2 2025 · Jun 30, 2025 −$250.62M
Net Income Q2 2025 · Mar 31, 2025 −$447.51M
Net Income Q2 2025 · Jun 30, 2024 $6.46M
Net Income Q2 2025 · Jun 30, 2024 $42.58M
Net Income Q2 2025 · Mar 31, 2024 $36.12M
Operating Income Q2 2025 · Jun 30, 2025 $115.58M
Operating Income Q2 2025 · Jun 30, 2025 −$184.81M
Operating Income Q2 2025 · Jun 30, 2024 −$701K
Operating Income Q2 2025 · Jun 30, 2024 $34.2M
Revenue Q2 2025 · Jun 30, 2025 $513.12M
Revenue Q2 2025 · Jun 30, 2025 $1.12B
Revenue Q2 2025 · Jun 30, 2024 $360.55M
Revenue Q2 2025 · Jun 30, 2024 $720.03M